Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gentle

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
British Journal of Cancer|March 31, 2005
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumourD Astuti, F Latif, K Wagner, et al.
Oncogene|February 16, 2010
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinomaM R Morris, C Ricketts, D Gentle, et al.
British Journal of Cancer|January 16, 2008
Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinomaM R Morris, D Gentle, M Abdulrahman, et al.
British Journal of Cancer|January 22, 2004
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinomaD Astuti, N F Da Silva, A Dallol, et al.
Epigenetics|January 27, 2015
Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomasA Alholle, A T Brini, J Bauer, et al.
Journal of Clinical Pathology|June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinomaM R Morris, E Maina, N V Morgan, et al.
Oncogene|October 20, 2010
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesisV K Hill, N Underhill-Day, D Krex, et al.
British Journal of Cancer|October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastomaD Astuti, M Morris, C Krona, et al.
Oncogene|December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinomaM R Morris, C J Ricketts, D Gentle, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
British Journal of Cancer|March 31, 2005
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumourD Astuti, F Latif, K Wagner, et al.
Oncogene|February 16, 2010
Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinomaM R Morris, C Ricketts, D Gentle, et al.
British Journal of Cancer|January 16, 2008
Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinomaM R Morris, D Gentle, M Abdulrahman, et al.
British Journal of Cancer|January 22, 2004
SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinomaD Astuti, N F Da Silva, A Dallol, et al.
Epigenetics|January 27, 2015
Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomasA Alholle, A T Brini, J Bauer, et al.
Journal of Clinical Pathology|June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinomaM R Morris, E Maina, N V Morgan, et al.
Oncogene|October 20, 2010
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesisV K Hill, N Underhill-Day, D Krex, et al.
British Journal of Cancer|October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastomaD Astuti, M Morris, C Krona, et al.
Oncogene|December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinomaM R Morris, C J Ricketts, D Gentle, et al.
Pageof 2